Top 100 Cited Articles on Lumbar Spondylolisthesis: A Bibliographic Analysis.

Bibliographic evaluation.The goal of this examine is to establish probably the most cited research on lumbar spondylolisthesis and report their affect in backbone discipline. Thomson Reuters Net of Science-Science Quotation Index Expanded was searched utilizing title-specific search “spondylolisthesis.”

 

All research printed in English language between 1900 and 2019 had been included with no restrictions. The highest 100 cited articles had been recognized utilizing “Occasions cited” arranging articles from excessive to low in accordance with quotation rely. Additional evaluation was made to acquire the next objects: article title, writer’s title and specialty, nation of origin, establishment, journal of publication, yr of publication, citations quantity, examine design.

gentaur
Gentaur

 

Outcomes

The quotation rely of the highest 100 articles ranged from 68 to 589. All printed between 1932 and 2016. Amongst 20 journals, Backbone had the very best variety of articles (49), with quotation variety of 6155 out of 13 618. Second ranked was the Journal of Bone and Joint Surgical procedure with 15 articles and whole citations of 3023. With regard to the first writer’s specialty, orthopedic surgeons contributed to the vast majority of high 100 record with 82 articles, and neurosurgery was the second specialty with 11 articles.

 

The USA had produced greater than half of the record with 59 articles. England was the second nation with 7 articles. Surgical administration of degenerative lumbar spondylolisthesis was the most typical mentioned subject.This text identifies the highest 100 influential articles on lumbar spondylolisthesis and acknowledges an vital facet of data evolution served by main researchers as they guided right this moment’s scientific choice making in spondylolisthesis.

 

Anti-Galectin 1/Lgals1 Antibody

A00470-1 100ug/vial
EUR 334

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 280

Recombinant Human Galectin-1 Protein

PROTP09382-1 50ug
EUR 317
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Anti-Galectin-3 Monoclonal Antibody

M00621-1 100ul
EUR 397
Description: Mouse Monoclonal Galectin-3 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat.

anti-Galectin 1

YF-PA12945 100 ug
EUR 403
Description: Rabbit polyclonal to Galectin 1

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 349

Anti-Galectin 1 Antibody

A00470-2 100ug/vial
EUR 294

Anti-Galectin-1 antibody

STJ93201 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-1.

Anti-Galectin-1 antibody

STJ98716 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-1.

anti- Galectin-1 antibody

FNab03314 100µg
EUR 505.25
Description: Antibody raised against Galectin-1

anti- Galectin-1 antibody

FNab03315 100µg
EUR 548.75
Description: Antibody raised against Galectin-1

Anti-Galectin 1 (1A8)

YF-MA13984 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin-1 antibody

PAab03314 100 ug
EUR 355

Anti-Galectin 1/LGALS1 Antibody

PA1422 100ug/vial
EUR 334

Anti-Galectin 1/LGALS1 Antibody

PB9240 100ug/vial
EUR 334

Anti-Galectin 1/Lgals1 Antibody

A00470 100ug/vial
EUR 334

Anti-Galectin 1 Biotinylated Antibody

A00470-Biotin 50ug/vial
EUR 294

Anti-galectin-1 (mouse) antibody

STJ72519 100 µg
EUR 359

anti-Galectin 1 (1E8-1B2)

LF-MA10174 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin-13 (GAL13) / Placental Protein 13 (PP13) Monoclonal Antibody

M08143-1 100ug/vial
EUR 397
Description: Mouse Monoclonal Galectin-13 (GAL13) / Placental Protein 13 (PP13) Antibody. Validated in IHC and tested in Human.

anti-Galectin 3

YF-PA24079 50 ul
EUR 334
Description: Mouse polyclonal to Galectin 3

anti-galectin 9

YF-PA24081 50 ul
EUR 334
Description: Mouse polyclonal to galectin 9

anti-Galectin 3

YF-PA12946 50 ug
EUR 363
Description: Mouse polyclonal to Galectin 3

anti-Galectin 3

YF-PA12947 100 ul
EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 3

YF-PA12948 100 ug
EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 8

YF-PA12951 50 ul
EUR 363
Description: Mouse polyclonal to Galectin 8

anti-Galectin 13

YF-PA18585 50 ug
EUR 363
Description: Mouse polyclonal to Galectin 13

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

LGALS8 Human, Galectin-8 Human Recombinant Protein, His Tag

PROTO00214-1 Regular: 10ug
EUR 317
Description: LGALS8 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 337 amino acids (1-317 a.a.) and having a molecular mass of 37.9 kDa. The LGALS8 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

LGALS3 Human, Galectin-3 Human Recombinant Protein, His Tag

PROTP17931-1 Regular: 25ug
EUR 317
Description: LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 270 amino acids (1-250 a.a.) and having a molecular mass of 28.3 kDa._x000D_ The LGALS3 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. _x000D_

LGALS7 Human, Galectin-7 Human Recombinant Protein, His Tag

PROTP47929-1 Regular: 20ug
EUR 317
Description: Galectin-7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 156 amino acids (1-136 a.a.) and having a molecular mass of 17.2kDa. ;The Galectin-7 is purified by proprietary chromatographic techniques.

Anti-human Galectin-3 antibody

STJ15100163 250 µg
EUR 336
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation

Human Galectin-3 (Gal-3) AssayMax ELISA Kit

EG3311-1 96 Well Plate
EUR 477

Human Galectin-4 (Gal-4) AssayMax ELISA Kit

EG3312-1 96 Well Plate
EUR 477

Human Galectin 1 Protein

20-abx066725
  • EUR 620.00
  • EUR 272.00
  • EUR 1859.00
  • EUR 732.00
  • EUR 453.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Recombinant Human Galectin-1

7-00427 10µg Ask for price

Recombinant Human Galectin-1

7-00428 50µg Ask for price

Recombinant Human Galectin-1

7-00429 1mg Ask for price

Human Galectin-1 (LGALS1)

1-CSB-EP012882HU
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-1 (LGALS1)

1-CSB-EP012882HUb1
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Galectin-1, human recombinant

4648-10
EUR 142

Galectin-1, human recombinant

4648-1000
EUR 1648

Galectin-1, human recombinant

4648-50
EUR 262

Anti-Galectin-9 Antibody

A03415 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Galectin-9 Antibody (LGALS9) detection.tested for WB in Human, Mouse, Rat.

 

 

Bibliographic overview on the state-of-the-art of strontium and zinc primarily based regenerative therapies. Current developments and scientific purposes.

 

Musculoskeletal issues similar to osteoporosis and rheumatoid arthritis are chargeable for greater than 25ok deaths yearly within the European Union and represent a persistent burden on the people that suffer from this situation. There is no such thing as a medical remedy for these illnesses and there are various therapies utilized which have restricted effectiveness and extreme unwanted effects over time.

Regenerative therapies are being studied as a possible remedy for musculoskeletal illnesses and are recognized for his or her upgrading results of the pure therapeutic processes carried out within the human physique.

 

It’s believed that each strontium and zinc play a vital function in bone and cartilage tissue formation, which has led many scientists to review the impact of together with these components to advertise tissue formation and inhibit its resorption.

 

On this overview, a deep evaluation is undertaken of probably the most related developments in strontium and zinc primarily based regenerative therapies that have occurred within the final 5 years, taking into account solely these research reporting vital progress in direction of actual scientific purposes.

 

This overview brings updated the state-of-the-art of strontium and zinc primarily based regenerative therapies as it’s believed that each have a selling impact on tissue formation and have a vital function inhibiting resorption in musculoskeletal issues.

 

Handsearching had finest recall however poor effectivity when exporting to a bibliographic software: case examine.

 

To check the effectiveness and effectivity of strategies used to establish and export convention abstracts right into a bibliographic administration software.

Case examine. The effectiveness and effectivity of strategies to establish and export convention abstracts introduced on the American Society of Hematology (ASH) convention 2016-2018 for a scientific overview had been evaluated.

A reference customary handsearch of convention proceedings was in comparison with: 1) contacting Blood (the journal who report ASH proceedings); 2) key phrase looking out; 3) looking out Embase; 4) looking out MEDLINE through EndNote; and 5) looking out CPCI-S. Effectiveness was decided by the variety of abstracts recognized in contrast with the reference customary, whereas effectivity was a comparability between the sources required to establish and export convention abstracts in comparison with the reference customary.

604 probably eligible and 15 confirmed eligible convention abstracts (abstracts included within the overview) had been recognized by the handsearch. Comparator 2 was the one technique to establish all abstracts and it was extra environment friendly than the reference customary. Comparators 1, and 3-5 missed quite a lot of eligible abstracts.

This examine raises probably regarding questions on trying to find conferences’ abstracts by strategies aside from immediately looking out the unique convention proceedings. Effectivity of exporting could be improved if journals permitted bulk downloads.

 

Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure

H3N23-A 100 ul
EUR 445

Influenza A H3 Antibody

abx021977-1mg 1 mg
EUR 878

Influenza A H3 Antibody

abx021978-1mg 1 mg
EUR 878

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-563 0.05 mg
EUR 527
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-564 0.05 mg
EUR 527
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A antibody

10-1096 500 ug
EUR 208
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1097 1 mg
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1098 1 mg
EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1099 1 mg
EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1100 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1101 1 mg
EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1102 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1103 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1241 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-1243 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-7866 1 mg
EUR 403
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-7867 1 mg
EUR 403
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50A 1 mg
EUR 503
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50B 1 mg
EUR 392
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50C 1 mg
EUR 392
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50D 1 mg
EUR 279
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50E 1 mg
EUR 279
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50F 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50G 1 mg
EUR 408
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50H 1 mg
EUR 541
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50I 1 mg
EUR 408
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50K 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50L 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50M 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50N 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50O 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50P 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50Q 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50R 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50S 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50T 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody

10-I50U 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Lung Tissue Lysate (Tumor)

1703-07 0.1 mg
EUR 280.25
Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)

1707-07 0.1 mg
EUR 280.25
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)

1710-07 0.1 mg
EUR 217.25
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

 

Leave a Reply

Your email address will not be published.